Tinea Corporis Market Size Has Rising Expenditure with Growth By Top Leaders Considering Sales Revenue

Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person. Tinea corporis is a fungal infection that is caused by tinea rubrum, trichophyton mentagrophytes and epidermophyton floccosum fungi.
This fungal infection mainly occurs in humid climatic condition. It is also known as ringworm infection. Tinea corporis infection occurs mostly on arms, legs or can also occur on different parts of body. The global Tinea Corporis Market Size is expected to see the growth in upcoming year due to entry of new drug product in market for treatment. Many key players in market are engaged in development of new drug product for tinea corporis treatment.
Global Tinea Corporis Market Size is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023.
Market Segmentation:
Global Tinea Corporis Market Size is segmented into drug type, diagnosis, treatment and end-users. Tinea Corporis Market Size on basis of drug types is segmented into antifungals, steroids and anti-infective combinations.
Global Tinea Corporis Market Size by Drug Type
  • Antifungals
  • Steroids
  • Anti-Infective Combinations
Global Tinea Corporis Market Size, by Diagnosis
  • Physical Exam

  • Imaging Tests
    Wood lamp (black light) examination
    Microscopy using potassium hydroxide (KOH)
    Fungal culture
    Skin biopsy
    Others
Global Tinea Corporis Market Size, by Treatment
  • Antifungal shampoos
  • Antifungal creams
  • Drugs
  • Others
Global Tinea Corporis Market Size, by End-Users
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Dermatology hospitals
  • Others
Top Industry Key players:
Some of the key players in the global Tinea Corporis Market Size are –
  • Teva Pharmaceuticals Inc.
  • Glenmark Pharmaceuticals Inc
  • NorthStar Rx LLC
  • Aurobindo Pharma Limited
  • Camber Pharmaceuticals Inc.
  • AvKare Inc.
  • Novartis AG
  • Sebela Pharmaceuticals Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd
  • Perrigo Company
  • Taro Pharmaceuticals. Inc.
  • Breckenridge Pharmaceutical Inc.
Browse Complete Premium Research Report Enabled with TOC at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838
LIST OF TABLES
Table 1 Global Tinea Corporis Market Size Synopsis, 2018–2023
Table 2 Global Tinea Corporis Market Size Estimates and Forecast, 2018–2023 (USD Million)
Table 3 Global Tinea Corporis Market Size, By Region, 2018–2023 (USD Million)
Table 4 Global Tinea Corporis Market Size, By Drug Type, 2018–2023 (USD Million)
Table 5 Global Tinea Corporis Market Size, By Diagnosis, 2018–2023 (USD Million)
Table 6 Global Tinea Corporis Market Size, By Treatment, 2018–2023 (USD Million)
Table 7 Global Tinea Corporis Market Size, By End-Users, 2018–2023 (USD Million0
…Continues.
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312

Comments

Popular posts from this blog

Breast Implants Market Advance Modifications by Types and Overall Business Outlook till 2023

eClinical Solutions Market Latest Trends, Growth Prospects and Competitive Analysis in Americas Market

Polarizing Beamsplitters (PBS) Market Growth Opportunities, Future Trends and Business Outlook to 2026 | IDA